Wild-derived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors

Journal of Virology

Volumn 73, Issue 12, 1999, Pages 10079-10085

  Velupillai, Palanivel ^a   Yoshizawa, Izumi ^a   Dey, Dilip C ^a   Nahill, Sharon R ^a   Carroll, John P ^a   Bronson, Roderick T ^a   Benjamin, Thomas L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CANCER SUSCEPTIBILITY; CYTOTOXIC T LYMPHOCYTE; GENE DELETION; IMMUNOSURVEILLANCE; INBRED STRAIN; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; TUMOR IMMUNITY;

EID: 0032710925     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.12.10079-10085.1999     Document Type: Article

References (39)

1. Allison, A. C., J. N. Monga, and V. Hammond. 1974. Increased susceptibility to virus oncogenesis of congenitally thymus-deprived nude mice. Nature (London) 252:746-747.
2. Bauer, P. H., C. Cui, T. Stehle, S. C. Harrison, J. A. DeCaprio, and T. L. Benjamin. 1999. Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse. J. Virol. 73: 5826-5832.
3. Behlke, M. A., H. S. Chou, K. Huppi, and D. Y. Loh. 1986. Murine T-cell receptor mutants with deletions of β-chain variable region genes. Proc. Natl. Acad. Sci. USA 83:767-771.
4. -/- double knockout mice. Int. J. Cancer 67:405-408.
5. Beutner, U., W. N. Frankel, M. S. Cote, J. M. Coffin, and B. T. Huber. 1992. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc. Natl. Acad. Sci. USA 89:5432-5436.
6. Bronson, R., C. Dawe, J. Carroll, and T. Benjamin. 1997. Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc. Proc. Natl. Acad. Sci. USA 94:7954-7958.
7. Callahan, R, W. Drohan, D. Gallahan, L, D'Hoostelaere, and M. Potter. 1982. Novel class of mouse mammary tumor virus-related DNA sequences found in all species of Mus, including mice lacking the virus proviral genome. Proc. Natl. Acad. Sci. USA 79:;4113-4117.
8. Carbone, F. R., C. Kurts, S. R. M. Bennett, J. F. A. P. Miller, and W. R. Heath. 1998. Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol. Today 19:368-373.
9. Carroll, J. P., J. S. Fung, R. T. Bronson, E. Razvi, and T. L. Benjamin. 1999. Radiation-resistant and radiation-sensitive forms of host resistance to polyomavirus. J. Virol. 73:1213-1218.
10. Dawe, C. J., R. Freund, G. Mandel, K. Balmer-Hofer, D. A. Talmage, and T. L. Benjamin. 1987. Variations in polyoma virus genotype in relation to tumor induction in mice: characterization of wild type strains with widely differing tumor profiles. Am. J. Pathol. 127:243-261.
11. Eddy, B. E. 1969. Polyoma virus, p. 1-114. In S. Gard, C. Hallawer, and K. F. Meyer (ed.), Virology monograph 7. Springer-Verlag, New York, N.Y.
12. Finke, J., S. Ferrone, A. Frey, A. Mufson, and A. Ochoa. 1999. Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol. Today 20:158-160.
13. Frankel, W. N., C. Rudy, J. M. Coffin, and B. T. Huber. 1991. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature (London) 349:526-528.
14. Freund, R., A. Calderone, C. J. Dawe, and T. L. Benjamin. 1991. Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen. J. Virol. 65:335-341.
15. Freund, R., C. J. Dawe, and T. L. Benjamin. 1988. Duplication of noncoding sequences in polyomavirus is required for the development of thymic tumors in mice. J. Virol. 62:3896-3899.
16. Freund, R., C. J. Dawe, J. P. Carroll, and T. L. Benjamin. 1992. Changes in frequency, morphology and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene. Am. J. Pathol. 141: 1409-1425.
17. Freund, R., T. Dubensky, R. Bronson, A. Sotnikov, J. Carroll, and T. Benjamin. 1992. Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host. Virology 191:724-731.
18. Gallahan, D., and R. Callahan. 1987. Mammary tumorigenesis in feral mice: identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors. J. Virol. 61:66-74.
19. Gross, L. G. 1983. Oncogenic viruses, 3rd ed., vol. 2, p. 737-828. Pergamon Press, Inc., Oxford, England.
20. Hahne, M., D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, J.-C. Cerottini, and J. Tschopp. 1996. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363-1366.
21. Ignatowicz, L., J. W. Kappler, P. Marrack, and M. T. Scherer. 1994. Identification of two Vβ7-specific viral superantigens. J. Immunol. 152:65-71.
22. Kozak, C., G. Peters, R. Pauley, V. Morris, R. Michalides, J. Dudley, M. Green, M. Davisson, O. Prakash, A. Vaidya, J. Hilgers, A. Verstraeten, N. Hynes, H. Diggelmann, D. Peterson, J. C. Cohen, C. Dickson, N. Sarkar, R. Nusse, H. Varmus, and R. Callahan. 1987. A standardized nomenclature for endogenous mouse mammary tumor viruses. J. Virol. 61:1651-1654.
23. Kurts, C., J. F. A. P. Miller, R. M. Subramaniam, F. R. Carbone, and W. R. Heath. 1998. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 188:409-414.
24. Laird, P. W., A. Zyderveld, K. Linders, M. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.
25. Law, L. W. 1966. Immunologic responsiveness and the induction of experimental neoplasms. Cancer Res. 24:1121-1132.
26. Law, L. W., and C. J. Dawe. 1960. Influence of total body X-irradiation on tumor induction by parotid tumor agent in adult mice. Proc. Soc. Exp. Biol. Med. 105:414-419.
27. Law, L. W., R. C. Ting, and E. Leckband. 1967. Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells. Proc. Natl. Acad. Sci. USA 57:1058-1075.
28. Lukacher, A. E., Y. Ma, J. P. Carroll, S. R. Abromson-Leeman, J. C. Laning, M. E. Dorf, and T. L. Benjamin. 1995. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp. Med. 181:1683-1692.
29. k-restricted epitope in the middle T protein. J. Immunol. 160:1724-1734.
30. s: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus. Virology 196:241-248.
31. β10-bearing T cells. Eur. J. Immunol. 21:3035-3040.
32. O'Connell, J., M. W. Bennet, G. C. O'Sullivan, J. K. Collins, and F. Shanahan. 1999. The fas counterattack: cancer as a site of immune privilege, Immunol. Today 20:46-52.
33. O'Connell, J., G. C. O'Sullivan, J. K. Collins, and F. Shanahan. 1996. The fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing fas ligand. J. Exp. Med. 184:1075-1082.
34. Rolph, M. S., K. I. Matthaei, F. R. Carbone, W. R. Heath, and I. A. Ramshaw. 1998. Loss of antiviral cytotoxic T-lymphocyte activity during high level antigen stimulation. Viral Immunol. 11:183-195.
35. Rudy, C. K., E. Kraus, E. Palmer, and B. T. Huber. 1992. Mls-1-like super-antigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7. J. Exp. Med. 175:1613-1621.
36. Sahli, R., R. Freund, T. Dubensky, R. Garcea, R. Bronson, and T. Benjamin. 1993. Defect in entry and altered pathogenicity of a polyoma virus mutant blocked in VP2 myristylation. Virology 192:142-143.
37. Sherer, M. T., L. Ignatowicz, G. M. Winslow, J. W. Kappler, and P. Marrack. 1993. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell Biol. 9:101-128.
38. c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis. Cell 59:55-65.
39. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. D. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.